AbCellera Biologics Inc. ABCL
10.47 USD -0.55 (-4.99%)
Regular-session close
10.30 -0.17 -1.62%
After hours · Nov 19, 7:50 PM ET
10.38 Day range 11.29
2.75 52-week range 15.02
- YTD
- +206.14%
- 1 year
- +190.03%
Revenue & Expenses
Revenue by
Revenue Profit Costs
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 75.13M | 28.83M | 38.02M | 485.42M | 375.20M | |
| 75.13M | 28.83M | 38.02M | 485.42M | 375.20M | |
| -217.10M | -314.77M | -237.21M | 216.51M | 204.41M | |
| -146.41M | -162.86M | -146.40M | 158.52M | 153.46M | |
| -0.49 | -0.55 | -0.51 | 0.50 | 0.48 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 153.51M | 181.32M | 158.32M | 411.54M | 501.14M | |
| 1.36B | 1.36B | 1.49B | 1.54B | 1.32B | |
| 390.05M | 304.47M | 335.78M | 307.63M | 292.84M | |
| 137.40M | 60.74M | 71.22M | 76.67M | 36.41M | |
| 966.90M | 1.06B | 1.15B | 1.23B | 1.03B |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -131.29M | -108.56M | -43.88M | 277.36M | 244.58M | |
| 87.75M | 121.41M | -221.11M | -352.63M | -332.25M | |
| 14.08M | 12.77M | 10.36M | -1.63M | -3.89M | |
| -42.77M | -78.40M | -76.95M | -70.66M | -58.45M | |
| -28.37M | 23.00M | -254.04M | -86.49M | -92.97M |
